Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 43Gastrointestinal 2Thoracic 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 3Ovarian Neoplasms 3Peritoneal Neoplasms 2Endometrial Neoplasms 2Uterine Neoplasms 1Uterine Cervical Dysplasia 1Stomach Neoplasms 1Papillomavirus Infections 1Neoplasms 1Motor Activity 1Lung Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Colonic Diseases 1Cervical Cancer Screening 1Breast Neoplasms 1

Interventions

pembrolizumab 33Paclitaxel 27Cyclophosphamide 25Carboplatin 23olaparib 21Fulvestrant 15fludarabine 14Trastuzumab 14aldesleukin 13Docetaxel 13Early Intervention, Educational 12Surveys and Questionnaires 11veliparib 10palbociclib 10Methods 10Gemcitabine 10Blood Specimen Collection 10Nivolumab 9Flow Cytometry 9Biopsy 9Bevacizumab 9sargramostim 8niraparib 7liposomal doxorubicin 7Therapeutics 7Taxes 7Standard of Care 7Psychiatric Rehabilitation 7Magnetic Resonance Spectroscopy 7talazoparib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Control Groups × Gynecologic × Clear all
NCT02991677 2024-08-06

Exercise Effect on Chemotherapy-Induced Neuropathic Pain

Baltimore VA Medical Center

Phase NA Active not recruiting
60 enrolled
BreastGastrointestinalGynecologicThoracic

Breast Neoplasms, Lung Neoplasms, Motor Activity, Ovarian Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡